Acrotac 25 mg Capsule

Composition of Acrotac 25 mg Capsule

Acrotac 25 mg Capsule contains Acitretin 25 mg (soft gelatin capsule). It belongs to the Retinoid (systemic) class of medicines.

Uses of Acrotac 25 mg Capsule

Treatment of severe psoriasis (including erythrodermic or pustular psoriasis) and other severe disorders of keratinisation when unresponsive to other therapies.

Key benefits

• Reduces thick scaly psoriatic plaques
• Helps control severe pustular/erythrodermic psoriasis
• Normalizes skin cell growth
• Improves redness and scaling
• Useful in severe keratinisation disorders

How Acrotac 25 mg Capsule works

Acitretin is an oral retinoid that normalizes epidermal cell growth and differentiation. It reduces excessive keratinocyte proliferation and inflammation, improving scaling, thickening and plaque formation.

How to take Acrotac 25 mg Capsule

Take by mouth as prescribed, usually once daily with the main meal (fat-containing food improves absorption). Swallow capsule whole; do not crush or chew. Dose and duration are individualized; follow dermatologist’s advice and attend regular monitoring.

Take it exactly as your doctor prescribed. Do not change the dose or stop early on your own.

Missed dose and overdose

If you miss a dose

Take it as soon as you remember. If your next dose is almost due, skip the one you missed — never take two doses together to catch up.

If you take too much

An overdose of this medicine is unlikely from skin use; swallowing the preparation may cause stomach upset. Do not wait for symptoms to appear — go to the nearest emergency department and take the pack or strip with you.

Side effects of Acrotac 25 mg Capsule

Most side effects of Acrotac are mild and settle as the body adjusts. Reported side effects include:

• Dry lips
• dry skin
• peeling
• itching
• dry eyes
• nosebleeds
• hair thinning
• headache
• increased liver enzymes
• increased triglycerides/cholesterol
• photosensitivity

Stop the medicine and seek help immediately for a rash, swelling of the face or lips, wheezing or difficulty breathing. Tell your doctor about any side effect that persists or worries you.

Safety advice for Acrotac 25 mg Capsule

Warnings and precautions

Highly teratogenic: contraindicated in pregnancy. Effective contraception is required for women of childbearing potential during treatment and for at least 3 years after stopping; regular pregnancy tests as advised. Do not donate blood during treatment and for 3 years after stopping. Avoid alcohol during treatment and for 2 months after stopping (can increase formation of etretinate and prolong teratogenic risk). Monitor liver function tests and lipid profile; use caution in liver disease, hyperlipidemia, diabetes, obesity. May cause mood changes, pseudotumor cerebri (severe headache/visual changes) and decreased night vision—avoid driving if affected. Avoid excessive sun/UV exposure.

Do not take Acrotac if

Not for anyone with a known allergy to this medicine or to any ingredient in the pack. Not for use on broken or infected skin unless prescribed.

Interactions with other medicines

Tetracyclines (risk of intracranial hypertension), vitamin A or other retinoids (additive toxicity), methotrexate (increased hepatotoxicity risk), alcohol (increases etretinate formation), phenytoin (protein binding interactions), progestin-only “minipill” contraception may be less reliable—use effective contraception as advised.

How to store Acrotac 25 mg Capsule

Store below 25°C in a cool, dry place, protected from light and moisture. Keep out of reach of children.

Expert advice for Acrotac 25 mg Capsule

Apply a thin layer to clean, dry skin. Wash your hands after use.

Manufacturer and class

Manufacturer:

SUN PHARMA 2

Therapeutic class:

Dermatological (Antipsoriatic)

Drug class:

Retinoid (systemic)